Chemical Structure (Tonmya 01)
Chemical structure diagram of Cyclobenzaprine Hydrochloride, the active ingredient in TONMYA tablets.*
Tonmya Tablet, Orally Disintegrating
Product Images NDC 70792-102
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tonmya (NDC 70792-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Tonix Medicines, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 Trial 1 (Tonmya 02)
A line graph depicting the LS mean change from baseline (SE) over 14 weeks comparing TONMYA and placebo. The x-axis represents weeks, and the y-axis shows mean change values. Two lines chart data points with error bars: a solid line for TONMYA and a dashed line for placebo.*
Figure 1 Trial 3 (Tonmya 03)
Line graph comparing LS mean change from baseline with standard error bars over 14 weeks for TONMYA versus placebo. The y-axis shows LS mean change from baseline, and the x-axis shows weeks. TONMYA demonstrates a greater decrease over time compared to placebo as indicated by separate lines and markers in the legend.*
Figure 2 Trial 1 (Tonmya 04)
A graph depicting the percentage of subjects versus percentage reduction in pain comparing TONMYA and placebo. The plot includes two lines: a solid line for TONMYA and a dashed line for placebo, showing the distribution of pain reduction percentages among subjects.*
Figure 2 Trial 3 (Tonmya 05)
A line graph comparing the percent of subjects versus the percentage reduction in pain for TONMYA and placebo. The horizontal axis represents percentage reduction in pain from 0% to 100%, and the vertical axis represents the percent of subjects from 0% to 100%. Two lines illustrate outcomes: a solid line for TONMYA and a dashed line for placebo, showing a higher percentage of subjects experiencing pain reduction with TONMYA across most values.*
Principal Display Panel (2.8 mg Tablet Bottle Label)
Packaging label for TONMYA (cyclobenzaprine hydrochloride) sublingual tablets, 2.8 mg strength, distributed by Tonix Medicines, Inc. The label states a package count of 90 tablets and includes dosage form and storage instructions, along with the NDC number 70792-102-90 and barcode.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
